MicroRNAs in addiction: Adaptation's middlemen

Molecular Psychiatry

Volumn 16, Issue 12, 2011, Pages 1159-1168

  Li, M D ^a   Van Der Vaart, A D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

addictions; mechanisms; miRNA; plasticity; regulation

Indexed keywords

ALCOHOL; COCAINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; MICRORNA; MICRORNA 124; MICRORNA 125B; MICRORNA 132; MICRORNA 181B; MICRORNA 29C; MICRORNA 30A 5P; MICRORNA 328; MICRORNA 93; NEUROTROPHIN; NICOTINE; UNCLASSIFIED DRUG;

ADAPTATION; ADDICTION; ALCOHOLISM; CELL STRUCTURE; COCAINE DEPENDENCE; DENDRITIC CELL; GENE CONTROL; GENE EXPRESSION; HUMAN; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEURONAL PLASTICITY; SUBSTANCE-RELATED DISORDERS;

EID: 81755179425     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.58     Document Type: Review

References (113)

1. Perkins DO, Jeffries C, Sullivan P. Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia. Mol Psychiatry 2005; 10: 69-78. (Pubitemid 40139589)
2. Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. Embo Reports 2001; 2: 986-991. (Pubitemid 33130603)
3. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355. (Pubitemid 39265675)
4. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10: 126-139.
5. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86. (Pubitemid 38055775)
6. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94: 776-780.
7. Sun JG, Liao RX, Qiu J, Jin JY, Wang XX, Duan YZ et al. Microarray-based analysis of microRNA expression in breast cancer stem cells. J Exp Clin Canc Res 2010; 29: 174.
8. Friedman RC, Farh KKH, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
9. Hobert O. Gene regulation by transcription factors and micro-RNAs. Science 2008; 319: 1785-1786. (Pubitemid 351451553)
10. Ashraf SI, McLoon AL, Sclarsic SM, Kunes S. Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila. Cell 2006; 124: 191-205. (Pubitemid 43069319)
11. Martin KC, Zukin RS. RNA trafficking and local protein synthesis in dendrites: an overview. J Neurosci 2006; 26: 7131-7134.
12. Lugli G, Torvik VI, Larson J, Smalheiser NR. Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. J Neurochem 2008; 106: 650-661.
13. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 2004; 5: R13.
14. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005; 310: 317-320. (Pubitemid 41457198)
15. Urdinguio RG, Fernandez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M et al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010; 5: 656-663.
16. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007; 317: 1220-1224.
17. Maes OC, Chertkow HM, Wang E, Schipper HM. MicroRNA: implications for Alzheimer disease and other human CNS disorders. Curr Genomics 2009; 10: 154-168.
18. Bicker S, Schratt G. microRNAs: tiny regulators of synapse function in development and disease. J Cell Mol Med 2008; 12: 1466-1476.
19. Sethi P, LukiwWJ. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 2009; 459: 100-104.
20. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA et al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 2007; 8: R27.
21. Zhu YL, Kalbfleisch T, Brennan MD, Li Y. A microRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophr Res 2009; 109: 86-89.
22. Huang WH, Li MD. Nicotine modulates expression of miR-140*, which targets the 30-untranslated region of dynamin 1 gene (Dnm1). Int J Neuropsychopharmacol 2009; 12: 537-546.
23. Huang WH, Li MD. Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry 2009; 65: 702-705.
24. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Ann Rev Neurosci 2006; 29: 565-598. (Pubitemid 44476856)
25. Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001; 2: 695-703. (Pubitemid 33674815)
26. Koob GF. The neurocircuitry of addiction: implications for treatment. Clin Neurosci Res 2005; 5: 89-101. (Pubitemid 41671138)
27. Kauer JA. Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol 2004; 66: 447-475. (Pubitemid 40614451)
28. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 2003; 26: 184-192. (Pubitemid 36412000)
29. Russo SJ, Dietz DM, Dumitriu D, Morrison JH, Malenka RC, Nestler EJ. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci 2010; 33: 267-276.
30. Kalivas PW, Volkow N, Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 2005; 45: 647-650. (Pubitemid 40320699)
31. Chang LF, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40. (Pubitemid 32225829)
32. Paroo Z, Ye XC, Chen S, Liu QH. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 2009; 139: 112-122.
33. Pietrzykowski AZ. The role of microRNAs in drug addiction: a big lesson from tiny molecules. Int Rev Neurobiol 2010; 91: 1001-1005.
34. Smalheiser NR, Lugli G. microRNA regulation of synaptic plasticity. Neuromol Med 2009; 11: 133-140.
35. Acheson A, Conover JC, Fandl JP, Dechiara TM, Russell M, Thadani A et al. A Bdnf autocrine loop in adult sensory neurons prevents cell death. Nature 1995; 374: 450-453.
36. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Ann Rev of Neurosci 2001; 24: 677-736. (Pubitemid 32695243)
37. Remenyi J, Hunter CJ, Cole C, Ando H, Impey S, Monk CE et al. Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J 2010; 428: 281-291.
38. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M et al. A brain-specific microRNA regulates dendritic spine development. Nature 2006; 439: 283-289. (Pubitemid 43128846)
39. Vo N, Klein ME, Varlamova O, Keller DM, Yamamoto T, Goodman RH et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci USA. 2005; 102: 16426-16431. (Pubitemid 41688930)
40. Hansen KF, Sakamoto K, Wayman GA, Impey S, Obrietan K. Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory. Plos One 2010; 5: e15497.
41. Endo M, Ohashi K, Sasaki Y, Goshima Y, Niwa R, Uemura T et al. Control of growth cone motility and morphology by LIM kinase and slingshot via phosphorylation and dephosphorylation of cofilin. J Neurosci 2003; 23: 2527-2537. (Pubitemid 36418586)
42. Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 2009; 11: 705-U736.
43. Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010; 65: 373-384.
44. Barco A, Alarcon JM, Kandel ER. Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 2002; 108: 689-703. (Pubitemid 34245387)
45. Benito E, Barco A. CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Trends Neurosci 2010; 33: 230-240.
46. Zhou Y, Won J, Karlsson MG, Zhou M, Rogerson T, Balaji J et al. CREB regulates excitability and the allocation of memory to subsets of neurons in the amygdala. Nat Neurosci 2009; 12: 1438-1443.
47. Dong Y, Green T, Saal D, Marie H, Neve R, Nestler EJ et al. CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci 2006; 9: 475-477.
48. Marin MT, Berkow A, Golden SA, Koya E, Planeta CS, Hope BT. Context-specific modulation of cocaine-induced locomotor sensitization and ERK and CREB phosphorylation in the rat nucleus accumbens. Eur J Neurosci 2009; 30: 1931-1940.
49. Moron JA, Gullapalli S, Taylor C, Gupta A, Gomes I, Devi LA. Modulation of opiate-related signaling molecules in morphinedependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology 2010; 35: 955-966.
50. Wu J, Xie XH. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol 2006; 7: R85.
51. Becskei A, Serrano L. Engineering stability in gene networks by autoregulation. Nature 2000; 405: 590-593. (Pubitemid 30367734)
52. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Current Biol 2002; 12: 735-739. (Pubitemid 34455427)
53. Visvanathan J, Lee S, Lee B, Lee JW, Lee SK. The microRNA miR-antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev 2007; 21: 744-749. (Pubitemid 46572354)
54. Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci USA. 2006; 103: 2422-2427. (Pubitemid 43271685)
55. Rajasethupathy P, Fiumara F, Sheridan R, Betel D, Puthanveettil SV, Russo JJ et al. Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 2009; 63: 803-817.
56. Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010; 466: 1105-1109.
57. Renthal W, Kumar A, Xiao GH, Wilkinson M, Covington HE, Maze I et al. Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 2009; 62: 335-348.
58. Alvarez-Saavedra M, Antoun G, Yanagiya A, Oliva-Hernandez R, Cornejo-Palma D, Perez-Iratxeta C et al. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum Mol Genet 2011; 20: 731-751.
59. Georgel PT, Horowitz-Scherer RA, Adkins N, Woodcock CL, Wade PA, Hansen JC. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem 2003; 278: 32181-32188. (Pubitemid 37048409)
60. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998; 19: 187-191. (Pubitemid 28248804)
61. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008; 320: 1224-1229. (Pubitemid 351929512)
62. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y et al. DNA methylation-related chromatin remodeling in activity-dependent Bdnf gene regulation. Science 2003; 302: 890-893. (Pubitemid 37339633)
63. Wu H, Tao JF, Chen PJ, Shahab A, Ge WH, Hart RP et al. Genomewide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Proc Natl Acad Sci USA. 2010; 107: 18161-18166.
64. Larimore JL, Chapleau CA, Kudo S, Theibert A, Percy AK, Pozzo-Miller L. Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis 2009; 34: 199-211.
65. Klein ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci 2007; 10: 1513-1514. (Pubitemid 350175879)
66. Lonetti G, Angelucci A, Morando L, Boggio EM, Giustetto M, Pizzorusso T. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol Psychiatry 2010; 67: 657-665.
67. Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2010; 107: 22687-22692.
68. Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q et al. Striatal microRNA controls cocaine intake through CREB signaling. Nature 2010; 466: 197-202.
69. Belin D, Everitt BJ. Cocaine seeking habits depend upon doparnine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 2008; 57: 432-441. (Pubitemid 351179162)
70. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 1997; 278: 58-63. (Pubitemid 27446271)
71. Carlezon WA, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N et al. Regulation of cocaine reward by CREB. Science 1998; 282: 2272-2275. (Pubitemid 29004079)
72. Im HI, Hollander JA, Bali P, Kenny PJ. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 2010; 13: 1120-1127.
73. Chang Q, Khare G, Dani V, Nelson S, Jaenisch R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 2006; 49: 341-348. (Pubitemid 43152236)
74. Zhou ZL, Hong EJ, Cohen S, Zhao WN, Ho HYH, Schmidt L et al. Brain-specific phosphorylation of MeCP2 regulates activitydependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006; 52: 255-269. (Pubitemid 44548348)
75. Schoenbaum G, Stalnaker TA, Shaham Y. A role for BDNF in cocaine reward and relapse. Nat Neurosci 2007; 10: 935-936. (Pubitemid 47185191)
76. Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 1999; 19: 4110-4122. (Pubitemid 29222283)
77. Choi KH, Whisler K, Graham DL, Self DW. Antisense-induced reduction in nucleus accumbens cyclic AMP response element binding protein attenuates cocaine reinforcement. Neuroscience 2006; 137: 373-383. (Pubitemid 43031504)
78. Le Foll B, Diaz J, Sokoloff P. A single cocaine exposure increases BDNF and D-3 receptor expression: implications for drugconditioning. Neuroreport 2005; 16: 175-178. (Pubitemid 40250395)
79. Chandrasekar V, Dreyer JL. microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci 2009; 42: 350-362.
80. Chandrasekar V, Dreyer JL. Regulation of MiR-124, Let-7d, and MiR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference. Neuropsychopharmacology 2011; 36: 1149-1164.
81. Luscher C, Malenka RC. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 2011; 69: 650-663.
82. Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S. A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet 2008; 17: 3030-3042.
83. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DEH, Truong HT et al. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005; 48: 303-314. (Pubitemid 41476363)
84. Sadri-Vakili G, Kumaresan V, Schmidt HD, Famous KR, Chawla P, Vassoler FM et al. Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci 2010; 30: 11735-11744.
85. Self DW, Genova LM, Hope BT, Barnhart WJ, Spencer JJ, Nestler EJ. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 1998; 18: 1848-1859. (Pubitemid 28103092)
86. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 2007; 10: 1029-1037. (Pubitemid 47185197)
87. Hnasko TS, Sotak BN, Palmiter RD. Morphine reward in dopamine-deficient mice. Nature 2005; 438: 854-857. (Pubitemid 41753067)
88. Huang W, Ma JZ, Payne TJ, Beuten J, Dupont RT, Li MD. Significant association of DRD1 with nicotine dependence. Hum Genet 2008; 123: 133-140.
89. Xing B, Kong H, Meng X, Wei SG, Xu M, Li SB. Dopamine D1 but not D3 receptor is critical for spatial learning and related signaling in the hippocampus. Neurosci 2010; 169: 1511-1519.
90. Brunzell DH, Mineur YS, Neve RL, Picciotto MR. Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference. Neuropsychopharmacology 2009; 34: 1993-2001.
91. Xu Q, Huang WH, Payne TJ, Ma JZ, Li MD. Detection of genetic association and a functional polymorphism of dynamin 1 gene with nicotine dependence in European and African Americans. Neuropsychopharmacology 2009; 34: 1351-1359.
92. Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997; 9: 482-497. (Pubitemid 27363951)
93. Whistler JL, Chuang HH, Chu P, Jan LY, von Zastrow M. Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 1999; 23: 737-746. (Pubitemid 29411563)
94. Artalejo CR, Elhamdani A, Palfrey HC. Sustained stimulation shifts the mechanism of endocytosis from dynamin-1-dependent rapid endocytosis to clathrin-and dynamin-2-mediated slow endocytosis in chromaffin cells (vol 99, pg 6358, 2002). Proc Natl Acad Sci USA. 2002; 99: 9082.
95. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 2008; 17: 1156-1168. (Pubitemid 351494187)
96. Volkow ND. Substance use disorders in schizophrenia-clinical implications of comorbidity. Schizophr Bull 2009; 35: 469-472.
97. Williams JM, Gandhi KK, Lu SE, Kumar S, Shen JW, Foulds J et al. Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette. Nicotine Tob Res 2010; 12: 855-859.
98. Lukiw WJ. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 2007; 18: 297-300.
99. Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 2008; 105: 6415-6420. (Pubitemid 351758360)
100. Holsinger RMD, McLean CA, Masters CL, Evin G, Beyreuther K. BACE and beta-secretase product CTF beta are increased in sporadic Alzheimer's disease brain. Neurobiol Aging 2002; 23: S177.
101. Fukumoto H, Cheung B, Hyman B, Irizarry M. beta-site amyloid precursor protein cleaving enzyme (BACE) activity is increased in temporal neocortex of Alzheimer's disease. Neurobiol Aging 2002; 23: S181.
102. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H et al. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann Neurol 1997; 42: 159-163. (Pubitemid 27340459)
103. Boissonneault V, Plante I, Rivest S, Provost P. MicroRNA-298 and MicroRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 2009; 284: 1971-1981.
104. Dolganiuc A, Petrasek J, Kodys K, Catalano D, Mandrekar P, Velayudham A et al. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res 2009; 33: 1704-1710.
105. Pietrzykowski AZ, Friesen RM, Martin GE, Puig SI, Nowak CL, Wynne PM et al. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 2008; 59: 274-287. (Pubitemid 352033687)
106. Shipston MJ. Alternative splicing of potassium channels: a dynamic switch of cellular excitability. Trends Cell Biol 2001; 11: 353-358. (Pubitemid 32900521)
107. Martin G, Puig SI, Pietrzykowski A, Zadek P, Emery P, Treistman S. Restricted cellular localization of a specific BKchannel subtype controls ethanol sensitivity in the nucleus accumbens. Alcohol Clin Exp Res 2004; 28: 61A.
108. Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F et al. High levels of dopamine D-2 receptors in unaffected members of alcoholic families:possible protective factors. Arch Gen Psychiatry 2006; 63: 999-1008. (Pubitemid 44330458)
109. Saba LM, Bennett B, Hoffman PL, Barcomb K, Ishii T, Kechris K et al. A systems genetic analysis of alcohol drinking by mice, rats and men: influence of brain GABAergic transmission. Neuropharmacology 2011; 60: 1269-1280.
110. Liu J, Yang AR, Kelly T, Puche A, Esoga C, June Jr HL et al. Binge alcohol drinking is associated with GABAA alpha2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala. Proc Natl Acad Sci USA 2011; 108: 4465-4470.
111. McClung CA, Nestler EJ. Regulation of gene expression and cocaine reward by CREB and Delta FosB. Nat Neurosci 2003; 6: 1208-1215. (Pubitemid 37346042)
112. Long JY, Wang Y,Wang WJ, Chang BHJ, Danesh FR. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 2010; 285: 23455-23463.
113. Santarelli DM, Beveridge NJ, Tooney PA, Cairns MJ. Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry 2011; 69: 180-187.